Congress is entering a critical week in efforts to renew the user fees that help fund the Food and Drug Administration. The question is how much the must-pass bill will become a vehicle for other health policy priorities.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,